Your browser doesn't support javascript.
loading
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.
Navar, Ann Marie; Peterson, Eric D; Li, Shuang; Robinson, Jennifer G; Roger, Veronique L; Goldberg, Anne C; Virani, Salim; Wilson, Peter W F; Nanna, Michael G; Lee, L Veronica; Elassal, Joseph; Wang, Tracy Y.
Afiliação
  • Navar AM; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Peterson ED; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Li S; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Robinson JG; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Roger VL; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Goldberg AC; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Virani S; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Wilson PWF; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Nanna MG; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Lee LV; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Elassal J; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
  • Wang TY; From the Department of Medicine (Cardiology), Duke Clinical Research Institute, Durham, NC (A.M.N., E.D.P., S.L., T.Y.W. M.G.N.); Department of Epidemiology, University of Iowa (J.G.R.); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.L.R.); Washington University, St. Louis, MO
Circ Cardiovasc Qual Outcomes ; 11(3): e004249, 2018 03.
Article em En | MEDLINE | ID: mdl-29545393

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Serviços de Saúde Comunitária / Inibidores de Hidroximetilglutaril-CoA Redutases / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Dislipidemias / Lipídeos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Serviços de Saúde Comunitária / Inibidores de Hidroximetilglutaril-CoA Redutases / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Dislipidemias / Lipídeos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article